This study tested a new drug combination called "BR3006" and its comparison to taking three separate drugs, "BR3006A", "BR3006B", and "BR3006C." We wanted to see how the body breaks down and uses these medicines (this is called pharmacokinetics) and check their safety. The study involved 40 healthy adults who took the medicines after eating. The study is open-label, meaning both the doctors and the participants knew what medication was being taken. It's a crossover study, meaning participants received both treatments at different periods.

• Duration: Participants will take part in two study periods, so you may need to plan for multiple clinic visits.
• Eligibility: You must be over 19, healthy, and understand the study details to join.
• Restrictions: If you've been in another study recently or have certain health issues, you might not qualify.

Participants must give written consent and will undergo various tests. Please ensure you are not pregnant or nursing if you're a female participant.